BioNTech SE Files Updated Articles of Association
Ticker: BNTX · Form: 6-K · Filed: Jun 17, 2025 · CIK: 1776985
| Field | Detail |
|---|---|
| Company | Biontech Se (BNTX) |
| Form Type | 6-K |
| Filed Date | Jun 17, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, legal-filing, articles-of-association
TL;DR
BioNTech SE updated its German Articles of Association, filed with the SEC today.
AI Summary
BioNTech SE filed a Form 6-K on June 17, 2025, to report an English translation of its current Articles of Association. These updated articles were registered with the commercial register in Germany.
Why It Matters
Changes to a company's articles of association can impact its corporate governance and operational framework, potentially affecting shareholder rights and strategic decisions.
Risk Assessment
Risk Level: low — This filing is administrative, providing an updated version of the company's governing documents without disclosing new financial or operational information.
Key Players & Entities
- BioNTech SE (company) — Registrant
- 0001776985-25-000043 (filing_id) — Accession Number
- June 17, 2025 (date) — Filing Date
FAQ
What is the purpose of this Form 6-K filing?
The purpose of this Form 6-K is to report an English translation of BioNTech SE's current Articles of Association, which have been registered with the commercial register.
When was this filing submitted to the SEC?
This filing was submitted to the SEC on June 17, 2025.
What type of document is being filed?
The document being filed is an English translation of BioNTech SE's current Articles of Association.
Where are BioNTech SE's principal executive offices located?
BioNTech SE's principal executive offices are located at An der Goldgrube 12, D-55131 Mainz, Germany.
Does BioNTech SE file annual reports under Form 20-F or Form 40-F?
BioNTech SE indicates that it files annual reports under Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 17, 2025 regarding BioNTech SE (BNTX).